Isolation of SMTP-3, 4, 5 and -6, novel analogs of staplabin, and their effects on plasminogen activation and fibrinolysis

Citation
K. Hasumi et al., Isolation of SMTP-3, 4, 5 and -6, novel analogs of staplabin, and their effects on plasminogen activation and fibrinolysis, J ANTIBIOT, 51(12), 1998, pp. 1059-1068
Citations number
27
Categorie Soggetti
Microbiology
Journal title
JOURNAL OF ANTIBIOTICS
ISSN journal
00218820 → ACNP
Volume
51
Issue
12
Year of publication
1998
Pages
1059 - 1068
Database
ISI
SICI code
0021-8820(199812)51:12<1059:IOS45A>2.0.ZU;2-X
Abstract
Four novel triprenyl phenol metabolites, designated SMTP-3, -4, -5, and -6, have been isolated from cultures of Stachybotrys microspora IFO 30018 by s olvent extraction and successive chromatographic fractionation using silica gel and silica ODS columns. A combination of spectroscopic analyses showed that SMTP-3, -4, -5, and -6 are staplabin analogs, containing a serine, a phenylalanine, a leucine or a tryptophan moiety in respective molecules in place of the N-carboxybutyl portion of the staplabin molecule. SMTP-4, -5, and -6 were active at 0.15 similar to 0.3 mM in enhancing urokinase-catalyz ed plasminogen activation and plasminogen binding to fibrin, as well as pla sminogen- and urokinase-mediated fibrinolysis. On the other hand, the conce ntration of staplabin required to exert such effects was 0.4 similar to 0.6 mM, and SMTP-3 was inactive at concentrations up to 0.45 mM.